Biote (BTMD) Change in Accured Expenses (2021 - 2026)

Biote (BTMD) has reported Change in Accured Expenses for 6 consecutive years, with $256000.0 the latest figure, recorded in Q1 2026.

• In Q1 2026, Change in Accured Expenses rose 109.61% year-over-year to $256000.0; the TTM figure through Mar 2026 stood at $178000.0 (down 94.34% YoY), while the FY2025 annual figure was -$2.7 million, down 159.22% from the prior year.
• Change in Accured Expenses came in at $256000.0 for Q1 2026 at Biote, up from -$1.3 million in the prior quarter.
• The five-year high for Change in Accured Expenses was $4.9 million in Q3 2023, with the low at -$26.1 million in Q2 2022.
• Average Change in Accured Expenses over 5 years is -$1.6 million, with a median of -$826000.0 recorded in 2023.
• Across the five-year window, Change in Accured Expenses sank 32986.68% in 2022 and soared 358.59% in 2024, its largest moves.
• Year by year, Change in Accured Expenses stood at $555000.0 in 2022, then tumbled by 421.08% to -$1.8 million in 2023, then jumped by 358.59% to $4.6 million in 2024, then plunged by 127.6% to -$1.3 million in 2025, then jumped by 120.13% to $256000.0 in 2026.
• According to Business Quant data, Change in Accured Expenses over the past three periods registered $256000.0, -$1.3 million, and $2.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.